Tris Pharma
Since July 2014, Norma has led our Regulatory Affairs teams for both brand and generic regulatory operations. She has over 35 years’ international and domestic regulatory experience in the pharmaceutical industry and her therapeutic areas of expertise include CNS, respiratory, cardiovascular, and endocrinology. Norma received a BS degree from the University of Rochester with a double major in Biology and Toxicology, and has proven success in NDA and ANDA submissions in her previous leadership roles with Ono Pharma, Celltech Americas, Medeva Americas, and Fisons Corporation.
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.